Hematologic Malignancies Grand Rounds



Speakers: Richard Lopez, MD


Topic: Relapsed DLBCL: CAR-T Cells for the Cure, or A Bridge to Allogeneic Transplant?


Date: Friday, May 18, 2018


NEW Time: 9:10am- 10:00am


Location: M224 Markee Classroom, Second Floor, Green Zone, Duke South Clinic's Davison Building.


Summary of Faculty Disclosure/Planning Committee
The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CE activity: Dr. Richard Lopez has no disclosures.


Joint Accreditation Statement


In support of improving patient care, Duke University Health System Department of Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.



Education Credits

Category 1*: Duke University Health System Department of Clinical Education and Professional Development designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.



It is the policy of the Duke University Health System Clinical Education and Professional Development to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity.



Speaker Name: 
Dr. Richard Lopez
M224 Markee Classroom
Durham, NC 27701
United States
Room Number: 
Session date: 
Friday, May 18, 2018 - 9:00am to 10:00am
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Attendance

Please login or register to take this course.